BENADRYL ALLERGY OTC
Generic Name and Formulations:
Diphenhydramine HCl 25mg; caps; tabs; dye-free liq-filled softgels.
McNeil Consumer Healthcare
Indications for BENADRYL ALLERGY:
Symptoms of upper respiratory allergies. Rhinorrhea/sneezing due to common cold.
25–50mg every 4–6hrs; max 300mg/day.
<6yrs: individualize. 6–12yrs: 12.5–25mg every 4–6hrs; max 150mg/day.
Neonates. Premature infants. Acute asthma. Concomitant diphenhydramine products (including topicals).
Asthma and lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Sodium-restricted diet. Children. Pregnancy (Cat.B in 3rd trimester): not recommended. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Potentiates anticholinergic effects with MAOIs.
Drowsiness, dizziness, anticholinergic effects, excitability in children.
Caps—24, 48; Tabs—24, 48, 100; Dye-free softgels—24; Allergy Liq—4oz, 8oz; Dye-free Liq—4oz; Inj—contact supplier
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Neuropathic Symptoms Worsen Quality of Life, Function in Hip, Knee Osteoarthritis
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- Switching From Buprenorphine-Naltrexone to XR-Naltrexone as Effective as XR-Naltrexone
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Human Diagnosis Project Aims to Address Challenges Among Uninsured
- Healthcare Technology Affects Younger Patient Satisfaction
- FDA Announces New Drug Shortages Task Force